EGFR and neoplasm: EGFR and PUMA seem to have a high co-expression in cell lines and primary specimens of different types of tumor cells, suggesting that EGFR overexpression might have anti-apoptotic and therefore oncogenic activity, even without the involvement of its kinase-dependent intracellular pathways [15].